Biblio Discovery — Demo Discovery Service

7 hasil untuk "Jonathan Kitonsa"

Menampilkan 1–7 · 0,16 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda

    Julius Kiwanuka; Jacinta Mukulu Waila; Methuselah Muhindo Kahungu dkk.

    PLOS ONE, Vol. 15 No. 4 · 2020 · Inggris · PLOS Scopus

    Background: Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence remain cornerstone of long-term viral suppression. In this era of test and treat (T&T) policy, ensuring that patients starting ART remain connected to HIV clinics is key to achieve the UNAIDS 90-90-90…

  2. Artikel Jurnal Teks lengkap

    The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: A retrospective cohort study

    Barbara Namugga; Ombeva Malande; Jonathan Kitonsa dkk.

    PLOS Global Public Health, Vol. 3 No. 7 · 2023 · Inggris · PLOS Scopus

    Over the recent years, the Ministry of Health in Uganda has reported multiple measles outbreaks in various districts despite the availability of a safe cost effective vaccine. Measles, especially among the unvaccinated can lead to serious complications including death while its management heavily…

  3. Artikel Jurnal Teks lengkap

    “Resilience amidst challenges”: Healthcare users’ experiences of access and utilisation of primary healthcare services during the COVID-19 pandemic in southwestern Uganda

    Rachel Kawuma; Joseph Katongole; Abdmagidu Menya dkk.

    PLOS Global Public Health, Vol. 5 No. 8 · 2025 · Inggris · PLOS Scopus

    Primary healthcare (PHC) systems are the first point of contact for healthcare users and are critical for disease prevention and early treatment. The COVID-19 pandemic overwhelmed PHC systems globally, including in sub-Saharan Africa, significantly impacting access to essential services. We…

  4. Artikel Jurnal Teks lengkap

    Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda

    Jonathan Kitonsa; Yunia Mayanja; Emmanuel Aling dkk.

    PLOS ONE, Vol. 14 No. 1 · 2019 · Inggris · PLOS Scopus

    Background: Cryptococcal meningitis (CCM) remains a leading cause of mortality amongst HIV infected patients in sub-Saharan Africa. When patients receive recommended therapy, mortality at 10 weeks has been reported to vary between 20 to 36%. However, mortality rate and factors affecting mortality…

  5. Artikel Jurnal Teks lengkap

    Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis

    Jonathan Kitonsa; Julius Kiwanuka; Zacchaeus Anywaine dkk.

    PLOS Neglected Tropical Diseases, Vol. 15 No. 3 · 2021 · Inggris · PLOS Scopus

    Background: Cryptococcal meningitis (CCM) remains one of the leading causes of mortality among HIV infected patients. Due to factors such as the severity of CCM pathology, the quality of life (QOL) of patients post-treatment is likely to be poor. Few studies have reported on QOL of CCM patients…

  6. Artikel Jurnal Teks lengkap

    Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda

    Jonathan Kitonsa; Rebecca Nsubuga; Yunia Mayanja dkk.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 11 · 2020 · Inggris · PLOS Scopus

    Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among HIV infected patients especially in sub-Saharan…

  7. Artikel Jurnal Teks lengkap

    Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda

    Jonathan Kitonsa; Onesmus Kamacooko; Ubaldo Mushabe Bahemuka dkk.

    PLOS ONE, Vol. 16 No. 5 · 2021 · Inggris · PLOS Scopus

    Background: Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials in a population of HCWs at three hospitals in…